Sinceri Senior Living Strengthens Leadership Structure to Fuel Operational Growth

April 17, 2025 9:00 AM

Sinceri Senior Living today announced a series of promotions of key executives to further align its team with the company's operational growth, ambitious vision, and unwavering commitment to exceptional senior living care."These promotions ensure our leadership structure accurately represents the dynamic contributions of our team," said Chris Belford, Chief Executive Officer at Sinceri Senior Living. "As we continue to enhance our operations and...

Read more

Proof-of-Concept Data for Rare Disease Indications MVID and SBS-IF for Jaguar Health's Crofelemer to be Presented at April 2025 ELITE PED-GI Congress

April 17, 2025 9:00 AM

Jaguar Health, Inc. (NASDAQ:JAGX) (Jaguar) family companies Napo Pharmaceuticals (Napo) and Napo Therapeutics today announced that preliminary results from the ongoing pediatric investigator-initiated trial (IIT) of a novel liquid formulation of crofelemer, Jaguar's novel plant-based anti-secretory prescription drug, for various congenital diarrheal disorders (CDD), including MVID and SBS with intestinal failure (SBS-IF), will be presented by...

Read more

Tribun Health Wins HealthTech 2025 Award in the Medical Diagnostics Category

April 17, 2025 8:00 AM

Tribun Health, a pioneer in AI-powered digital pathology, is proud to announce its victory at the HealthTech 2025 Awards organized by France Biotech. The award, received in the Medical Diagnostics category, recognizes our commitment to transform diagnostic practices through innovative and impactful solutions.Jean-François Pomerol, CEO of Tribun Health, had the honor of accepting this distinction during the ceremony held at the Théâtre de la Tour...

Read more

NHI Mails Letter to Stockholders Highlighting Superior Shareholder Returns and Refreshed Board

April 17, 2025 6:00 AM

National Health Investors, Inc. (NYSE:NHI) ("NHI" or "the Company") announced today that it has mailed a letter to stockholders in connection with its upcoming Annual Meeting of Stockholders, which is scheduled to be held virtually on May 21, 2025. Stockholders of record as of the close of business on March 28, 2025, are entitled to vote at the meeting. The letter urges stockholders vote on the WHITE proxy card "FOR" the election of NHI's highly...

Read more

MedMira Inc. and Lovell Announce Partnership to Increase Access to Reveal(R) G4 HIV-1/2 rapid test for VA, Department of Defense

April 17, 2025 6:00 AM

MedMira Inc. (MedMira) (TSXV:MIR) and Lovell® Government Services announced today that they have partnered to serve federal healthcare systems such as the Veterans Health Administration (VHA), the Military Health System (MHS), and the Indian Health Service (IHS). Lovell Government Services will serve as MedMira's Service-Disabled Veteran-Owned Small Business (SDVOSB) vendor to serve these customers through federal contracting systems.The Reveal®...

Read more

DEA Diversion Bureaucracy Undermines President Trump's America Pharmaceutical First Agenda

April 17, 2025 5:00 AM

As President Trump's administration pushes to revitalize domestic pharmaceutical manufacturing under the "America First Pharmaceutical" mantra, a glaring contradiction has emerged within the Drug Enforcement Administration (DEA). The agency's prolonged bureaucratic delays in approving pharmaceutical marijuana (MMJ BioPharma Cultivation) manufacturing applications are forcing U.S. drugmakers to relocate operations abroad-undermining both economic...

Read more

Strengthening Reputation: Bioz Partners With RBD Instruments to Leverage AI Product Validation

April 17, 2025 4:00 AM

Bioz, Inc. the frontrunner in AI-powered product credibility for research, is thrilled to unveil its latest partnership with RBD Instruments, a developer and provider of instrumentation related to surface analysis and materials science. This partnership integrates Bioz Badges onto all of RBD Instruments' product web pages, elevating the online presence and validation of RBD Instruments' products with evidence-based insights.RBD Instruments is...

Read more

NHS EPR Market Faces Crossroads as Structural Reforms Fuel Uncertainty, Black Book UK Survey

April 17, 2025 3:00 AM

A newly released survey conducted by Black Book Research reflects growing attention among UK healthcare leaders to the potential impact of NHS restructuring on digital health planning-specifically, the procurement and use of electronic patient record (EPR) systems. The findings are based on responses from 240 senior decision-makers in NHS hospitals and Integrated Care Systems (ICSs),Respondents shared expectations on how decentralization or...

Read more

Evotec SE Unveils New Strategy and Provides 2025 Guidance Bolstered by Strong Q4 2024 Results

April 17, 2025 1:45 AM

Evotec SE (Frankfurt Stock Exchange:EVT, MDAX/TecDAX, ISIN:DE0005664809; NASDAQ:EVO) today announced its financial results for FY 2024, provided guidance for FY 2025 and outlook for 2028 reflecting the path to sustainable profitable growth, following the completion of its strategic review process.Dr Christian Wojczewski, Chief Executive Officer of Evotec, said:"Evotec's ambitious new direction paves the way for sustainable profitable long-term...

Read more

Onco-Innovations Announces Private Placement

April 16, 2025 7:30 PM

Onco-Innovations Limited (CSE:ONCO)(Frankfurt:W1H, WKN: A3EKSZ)(OTCQB:ONNVF) ("Onco" or the "Company") announces that it intends to complete a non-brokered private placement (the "Private Placement") of up to 400,000 units of the Company (the "Units") at a price of $1.50 per Unit, for aggregate gross proceeds of up to $600,000.Each Unit shall consist of one common share (each a "Share") and one common share purchase warrant (each whole warrant,...

Read more

Protagonist Therapeutics Reports Granting of Inducement Award

April 16, 2025 4:05 PM

Protagonist Therapeutics, Inc. ("Protagonist" or the "Company"), a clinical-stage biopharmaceutical company pioneering the discovery and development of peptide-based therapeutics, today announced that on April 15, 2025 (the "Grant Date"), it issued an equity inducement award to a new employee upon his commencement of employment with the Company in accordance with the terms of his employment offer letter. The award was granted under the Company's...

Read more

Surgeons Perform Life-Changing Total Hip Replacement for Three-Legged Cat

April 16, 2025 12:00 PM

Known for its advanced veterinary medicine, the Veterinary Referral Center of Central Oregon offers emergency and specialty services to the Pacific Northwest region. With a state-of-the-art facility and a team of board-certified professionals, VRCCO provides the technology and expertise required to tackle complex cases and achieve results that may otherwise not be possible. A notable example is a feline total hip replacement case brought to...

Read more

Behavioral Innovations Expands Into Maryland, Bringing Expert ABA Therapy to Children With Autism

April 16, 2025 12:00 PM

Behavioral Innovations, a leading provider of Applied Behavior Analysis (ABA) therapy for children with autism, has announced its expansion into Maryland with the opening of new state-of-the-art ABA centers. This marks a significant milestone in the organization's 25-year commitment to delivering compassionate, evidence-based autism care.As Maryland experiences a growing prevalence of autism, the need for accessible, high-quality services has...

Read more

Phase 1 Equity Welcomes Respected Texas Orthodontic Practice

April 16, 2025 11:00 AM

Phase 1 Equity, a doctor-owned, doctor-led, and doctor-governed platform for orthodontists and pediatric dentists, is excited to welcome a leading multi-site provider of orthodontics practice in Texas to its growing network.Known for delivering exceptional care through advanced technology - including 3D imaging, an in-house lab, and a wide range of treatment options - the practice brings with it a strong culture of innovation, trust, and...

Read more

SpendMend Names Curtis McEntire as Chief Product Officer

April 16, 2025 9:00 AM

SpendMend, a leader in cost cycle management solutions for healthcare, has promoted Curtis McEntire to Chief Product Officer (CPO). In this role, McEntire will oversee the development, enhancement, and delivery of existing and future technology products within the SpendMend suite of solutions.McEntire brings deep expertise in product innovation and healthcare technology. In 2019, he co-founded Trulla, the healthcare industry's leading pharmacy...

Read more

DistillerSR Recognized Among the Top 35% of Global Organizations Rated by EcoVadis for Business Sustainability

April 16, 2025 9:00 AM

DistillerSR® Inc., the market leader in AI-enabled literature review automation and evidence management, and creator of DistillerSR®, today announced that it has achieved a Bronze Medal rating from EcoVadis, a global leader in business sustainability standard assessments. The rating recognizes DistillerSR among the top 35% of global organizations and top 19% within its industry as rated by EcoVadis on its 21 sustainability criteria across four...

Read more

MIRA Pharmaceuticals Announces Positive Results for Ketamir-2 in Diabetic Neuropathy Animal Model, Reinforcing Confidence Ahead of Phase I Completion

April 16, 2025 8:00 AM

MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA), or MIRA, a clinical-stage pharmaceutical company focused on developing novel therapeutics for neurologic and neuropsychiatric disorders, today announced compelling data demonstrating the efficacy of the oral ketamine analog, Ketamir-2, in a validated animal model of diabetic neuropathy.In the study, Type 2 diabetes was induced in rats using a high-fat diet combined with a low dose of Streptozotocin...

Read more

Black Book Expands 2025 RCM KPI Framework to Capture AI, Outsourcing and Financial Resilience Trends

April 16, 2025 8:00 AM

Black Book Research, a leading independent healthcare technology research firm, has released its fully updated and expanded 2025 Key Performance Indicator (KPI) Framework for Revenue Cycle Management (RCM). In response to record inflation in healthcare operations, widespread labor shortages, and growing pressure on financial margins, this next-generation KPI model reflects today's RCM landscape - driven by generative AI, outsourcing...

Read more

Regenerative Medical Technologies Group Increased 2024 Sales by 70% Year Over Year with Increased Q4 Sales by 146% Year Over Year and Achieved Positive Operating Income for 2024

April 16, 2025 7:00 AM

Regenerative Medical Technologies Group, Inc. (the "Company" or "RMTG"), a regenerative medicine company, is pleased to announce that it closed its 2024 fiscal year with approximately $4.1 million in sales, a more than 70% increase over 2023 levels and achieved positive operating income for all of 2024 (defined below). The Company also increased Q4 sales of this year by 146% compared to Q4 sales of last year.For fiscal 2024, the company only...

Read more

Clinical Trials Imaging Innovator Yunu Raises Oversubscribed Funding Round Led by Spring Mountain Capital

April 16, 2025 7:00 AM

Yunu, provider of transformative clinical trials imaging workflow solutions, secured an investment led by Spring Mountain Capital, affirming Yunu's position as an emerging category leader and proven innovator within the clinical trial imaging market. Yunu's platform delivers next-generation trial imaging workflow and ensures fast delivery of operational and clinical insights to sponsors."At Spring Mountain Capital, we look to invest in only the...

Read more